Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features with type 2 diabetes (T2D), resulting in inappropriate treatment strategies ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after progression on prior treatments. Continuing cemiplimab post-progression can ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers like non-small cell lung cancer (NSCLC) is expected to evolve toward more ...

Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...